Skip to main content

Advertisement

Table 1 Demographics and baseline characteristics, treated set

From: Treatment of acute rhinitis with a nasal spray containing tramazoline and essential oils: a multicenter, uncontrolled, observational trial

  Children Adolescents Adults Total
Patients, N (%) 108 (36.0) 30 (10.0) 162 (54.0) 300 (100)
Mean age in years (SD) 8.4 (2.0) 14.6 (1.3) 42.1 (15.9) 27.2 (20.0)
Sex, N (%)
 Female 37 (34.3) 15 (50.0) 94 (58.0) 146 (48.7)
 Male 71 (65.7) 15 (50.0) 68 (42.0) 154 (51.3)
Height (SD) 134 (15.1) 167 (16.9) 173 (9.8) 158 (22.1)
Weight (SD) 31.8 (10.2) 59.6 (16.1) 75.3 (18.2) 58 (25.5)
Mean days since symptom onset (SD) 1.3 (1.2) 1.1 (1.9) 1.4 (1.9) 1.3 (1.7)
Baseline mean symptom score (SD) 2.1 (0.6) 2.1 (0.6) 2.1 (0.6) 2.1 (0.6)
Pretreated with other medications, N (%) 8 (7.4) 6 (20.0) 30 (18.5) 44 (14.7)
Concomitant diagnosis, N (%)a 48 (44.4) 8 (26.7) 45 (27.8) 101 (33.7)
Ear and labyrinth disorders 22 (20.4) 4 (13.3) 5 (3.1) 31 (10.3)
Respiratory, thoracic and mediastinal disorders 21 (19.4) 2 (6.7) 3 (1.9) 26 (8.7)
Vascular disorders 0 (0.0) 0 (0.0) 18 (11.1) 18 (6.0)
Gastrointestinal disorders 4 (3.7) 0 (0.0) 13 (8.0) 17 (5.7)
Concomitant medications, N (%)b 49 (45.4) 7 (23.3) 45 (27.8) 101 (33.7)
Antibiotics, N (%) 31 (28.7) 3 (10.0) 4 (2.5) 38 (12.7)
Smoker, N (%) 0 (0.0) 0 (0.0) 23 (14.2) 23 (7.7)
  1. aConcomitant diagnosis is listed only for those categories including >5 % of patients
  2. bConcomitant medications are listed only for those categories including >5 % of patients